Jump to content

ATC code J02

From Wikipedia, the free encyclopedia

ATC code J02 Antimycotics for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup J02 is part of the anatomical group J Antiinfectives for systemic use.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QJ02.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

J02A Antimycotics for systemic use

[edit]
J02AA01 Amphotericin B
J02AA02 Hachimycin

J02AB Imidazole derivatives

[edit]
J02AB01 Miconazole
J02AB02 Ketoconazole
QJ02AB90 Clotrimazole

J02AC Triazole and tetrazole derivatives

[edit]
J02AC01 Fluconazole
J02AC02 Itraconazole
J02AC03 Voriconazole
J02AC04 Posaconazole
J02AC05 Isavuconazole
J02AC06 Oteseconazole

J02AX Other antimycotics for systemic use

[edit]
J02AX01 Flucytosine
J02AX04 Caspofungin
J02AX05 Micafungin
J02AX06 Anidulafungin
J02AX07 Ibrexafungerp
J02AX08 Rezafungin acetate

References

[edit]
  1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. ^ "ATC/DDD Index 2022: code J02". WHO Collaborating Centre for Drug Statistics Methodology.
  5. ^ "ATCvet Index 2022: code QJ02". WHO Collaborating Centre for Drug Statistics Methodology.